Author

Fabiana Zingone

Quantifying the burden
Quantifying the burden

Fabiana Zingone

NEGATIVE IMPACT OF INFLAMMATORY BOWEL DISEASE ON WOMEN’S REPRODUCTIVE LIFE: A SURVEY-BASED CONTROLLED STUDY
NEGATIVE IMPACT OF INFLAMMATORY BOWEL DISEASE ON WOMEN’S REPRODUCTIVE LIFE: A SURVEY-BASED CONTROLLED STUDY

Fabiana Zingone  et al.

UEG Guidelines Webinar #11 | Abdominal pain & diarrhoea: Guidelines-based patient management
UEG Guidelines Webinar #11 | Abdominal pain & diarrhoea: Guidelines-based patient management

Fabiana Zingone  et al.

DUODENAL HISTOLOGICAL FINDINGS AND RISK OF CELIAC DISEASE IN SUBJECTS WITH AUTOIMMUNE ATROPHIC GASTRITIS: A RETROSPECTIVE EVALUATION
DUODENAL HISTOLOGICAL FINDINGS AND RISK OF CELIAC DISEASE IN SUBJECTS WITH AUTOIMMUNE ATROPHIC GASTRITIS: A RETROSPECTIVE EVALUATION

Fabiana Zingone  et al.

Chronic diarrhoea in an older adult
Chronic diarrhoea in an older adult

Fabiana Zingone

COMPARISON OF OUTCOMES BETWEEN DIRECT OR STRUCTURED PEDIATRIC-TO-ADULT HEALTHCARE TRANSITION IN COELIAC DISEASE
COMPARISON OF OUTCOMES BETWEEN DIRECT OR STRUCTURED PEDIATRIC-TO-ADULT HEALTHCARE TRANSITION IN COELIAC DISEASE

TELEMEDICINE IN THE COVID-19 ERA FOR LIVER TRANSPLANT RECIPIENTS: AN ITALIAN LOCKDOWN AREA EXPERIENCE
TELEMEDICINE IN THE COVID-19 ERA FOR LIVER TRANSPLANT RECIPIENTS: AN ITALIAN LOCKDOWN AREA EXPERIENCE

Fabiana Zingone  et al.

RISK OF PREVALENT ASTHMA AMONG CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED BIRTH COHORT STUDY
RISK OF PREVALENT ASTHMA AMONG CHILDREN AFFECTED BY INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED BIRTH COHORT STUDY

Fabiana Zingone  et al.

TELEMEDICINE IN THE COVID-19 LOCKDOWN: IMPLEMENTATION FROM 0% TO 100% IN AN ITALIAN CELIAC DISEASE-DEVOTED CLINIC
TELEMEDICINE IN THE COVID-19 LOCKDOWN: IMPLEMENTATION FROM 0% TO 100% IN AN ITALIAN CELIAC DISEASE-DEVOTED CLINIC

Fabiana Zingone  et al.

BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS
BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS

Fabiana Zingone  et al.

THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY
THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY

Fabiana Zingone  et al.

SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY
SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY

Fabiana Zingone  et al.

USTEKINUMAB TREATMENT IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A REAL-WORLD COMPARISON BETWEEN ITS EFFECTIVENESS AND SAFETY IN THIS TWO POPULATIONS
USTEKINUMAB TREATMENT IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A REAL-WORLD COMPARISON BETWEEN ITS EFFECTIVENESS AND SAFETY IN THIS TWO POPULATIONS

Fabiana Zingone  et al.

COMPARISON OF OUTCOMES BETWEEN DIRECT OR STRUCTURED PEDIATRIC-TO-ADULT HEALTHCARE TRANSITION IN COELIAC DISEASE
COMPARISON OF OUTCOMES BETWEEN DIRECT OR STRUCTURED PEDIATRIC-TO-ADULT HEALTHCARE TRANSITION IN COELIAC DISEASE

Fabiana Zingone  et al.

LONG-TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY AND FACTORS INFLUENCING RESPONSE
LONG-TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY AND FACTORS INFLUENCING RESPONSE

Fabiana Zingone  et al.

NUTRITIONAL STATUS ASSESSMENT IN COELIAC DISEASE
NUTRITIONAL STATUS ASSESSMENT IN COELIAC DISEASE

Fabiana Zingone  et al.

TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Fabiana Zingone  et al.

RISK OF COVID-19 IN CELIAC DISEASE PATIENTS
RISK OF COVID-19 IN CELIAC DISEASE PATIENTS

Fabiana Zingone  et al.

RISK FACTORS OF MALIGNANCIES IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER EXPERIENCE
RISK FACTORS OF MALIGNANCIES IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER EXPERIENCE

Fabiana Zingone  et al.

SODIUM BUTYRATE SUPPLEMENTATION SIGNIFICANTLY IMPROVED CLINICAL OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE – RESULTS FROM A RANDOMISED PLACEBO-CONTROLLED STUDY
SODIUM BUTYRATE SUPPLEMENTATION SIGNIFICANTLY IMPROVED CLINICAL OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE – RESULTS FROM A RANDOMISED PLACEBO-CONTROLLED STUDY

Fabiana Zingone  et al.

Item 1 - 20 / 33
1
2